Pharsight Partners with InforSense on Software Distribution in China
Pharsight Corporation (PHST) has signed a deal with InforSense under which InforSense will distribute Pharsight’s early stage clinical development management software in China. InforSense will be responsible for marketing and distribution, as well as end-user training, maintenance and support services. InforSense is based in London, though it has established a Shanghai office. InforSense provides predictive intelligence software to a variety of industries, including healthcare and biotechnology.
Pharsight's software provides pharmacokinetic and pharmacodynamic (PK/PD) analysis and trial simulation, including support for reporting, archiving, and data visualization. Also, Pharsight and InforSense initiated a strategic partnership that will deliver translational research solutions to the pharmaceutical industry. The strategic partnership includes opportunities for product-based collaborations to use biomarkers in clinical PK/PD modeling.
In September, Pharsight signed a definitive agreement under which it will be acquired by the Tripos, a private company, for $57 million. Tripos produces Sybyl, a molecular modeling software package.
Disclosure: none.
Related Articles
|
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Trading Center
- Free E-Newsletters
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Advertise With Us
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Legal
- Terms of Use
- Privacy
- Copyright
More by ChinaBio Today